- Home
- RCEL vs SRV Comparison
RCEL vs SRV Comparison
Compare RCEL & SRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCEL
- SRV
- Stock Information
- Founded
- RCEL N/A
- SRV 2007
- Country
- RCEL United States
- SRV United States
- Employees
- RCEL N/A
- SRV N/A
- Industry
- RCEL Medical/Dental Instruments
- SRV Finance Companies
- Sector
- RCEL Health Care
- SRV Finance
- Exchange
- RCEL Nasdaq
- SRV Nasdaq
- Market Cap
- RCEL 161.5M
- SRV 176.7M
- IPO Year
- RCEL N/A
- SRV N/A
- Fundamental
- Price
- RCEL $5.32
- SRV $42.00
- Analyst Decision
- RCEL Strong Buy
- SRV
- Analyst Count
- RCEL 4
- SRV 0
- Target Price
- RCEL $16.50
- SRV N/A
- AVG Volume (30 Days)
- RCEL 326.4K
- SRV 33.9K
- Earning Date
- RCEL 08-07-2025
- SRV 01-01-0001
- Dividend Yield
- RCEL N/A
- SRV 13.38%
- EPS Growth
- RCEL N/A
- SRV N/A
- EPS
- RCEL N/A
- SRV N/A
- Revenue
- RCEL $71,661,000.00
- SRV N/A
- Revenue This Year
- RCEL $57.16
- SRV N/A
- Revenue Next Year
- RCEL $36.69
- SRV N/A
- P/E Ratio
- RCEL N/A
- SRV N/A
- Revenue Growth
- RCEL 41.35
- SRV N/A
- 52 Week Low
- RCEL $4.71
- SRV $30.73
- 52 Week High
- RCEL $14.16
- SRV $44.30
- Technical
- Relative Strength Index (RSI)
- RCEL 39.85
- SRV 59.15
- Support Level
- RCEL $4.71
- SRV $40.67
- Resistance Level
- RCEL $5.55
- SRV $42.43
- Average True Range (ATR)
- RCEL 0.29
- SRV 0.61
- MACD
- RCEL 0.08
- SRV -0.03
- Stochastic Oscillator
- RCEL 41.03
- SRV 77.12
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
About SRV NXG Cushing Midstream Energy Fund of Beneficial Interest
NXG Cushing Midstream Energy Fund is a non-diversified, closed-end management investment company with an investment objective of seeking a high after-tax total return from a combination of capital appreciation and current income. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in midstream energy investments.